10 December 2019 : Clinical Research
Analysis of Homogeneous and Heterogeneous Factors for Bone Metastasis in Esophageal Cancer
Jin Zhang1ABG, Wenjuan Ma2CEG, Haixiao Wu1BC, Jun Wang3BCF, Yile Lin1BCF, Xin Wang4ABCFG, Chao Zhang1AEFG*DOI: 10.12659/MSM.920483
Med Sci Monit 2019; 25:9416-9425
Abstract
BACKGROUND: Esophageal cancer is a common cancer worldwide. We performed the present study to assess the homogeneous and heterogeneous risk and prognostic factors of bone metastasis (BM) in esophageal cancer patients using data extracted from the Surveillance, Epidemiology, and End Results (SEER) database.
MATERIAL AND METHODS: Data from patients with esophageal cancer in the SEER database from 2010 to 2016 were extracted to reveal the risk factors for BM through univariable and multivariable logistic regression. Cox hazard regression analysis was used to evaluate the prognostic factors in esophageal cancer patients with BM from 2010 to 2015.
RESULTS: A total of 2075 (8.0%) patients with initial bone metastasis were diagnosed from among 25 955 patients with esophageal cancer from 2010 to 2016. Male sex, T4 stage, brain metastasis, and liver metastasis were common risk factors for the occurrence and prognosis of BM. Patients with age younger than 67 years, grade III, higher N stage (N1, N2, and N3), histological subtype of esophageal adenocarcinoma or others, and lung metastasis were also more likely to experience bone metastasis, while unmarried patients were associated with shorter survival.
CONCLUSIONS: The prevalence of initial bone metastasis was approximately 8.0% in esophageal cancer patients. More attention should be paid to patients with revealed risk and prognostic factors because these factors can guide individualize bone metastasis screening and treatment of esophageal cancer patients.
Keywords: Esophageal Neoplasms, Risk Factors, SEER Program, Bone Neoplasms, Multivariate Analysis, Prevalence, Proportional Hazards Models
Editorial
01 January 2025 : Editorial
Editorial: The Human Cell Atlas. What Is It and Where Could It Take Us?DOI: 10.12659/MSM.947707
Med Sci Monit 2025; 31:e947707
In Press
Clinical Research
Impact of Periodontal Treatment on Early Rheumatoid Arthritis and the Role of Porphyromonas gingivalis Anti...Med Sci Monit In Press; DOI: 10.12659/MSM.947146
Clinical Research
C-Reactive Protein, Uric Acid, and Coronary Artery Ectasia in Patients with Coronary Artery DiseaseMed Sci Monit In Press; DOI: 10.12659/MSM.947158
Clinical Research
Effects of Remote Exercise on Physical Function in Pre-Frail Older Adults: A Randomized Controlled TrialMed Sci Monit In Press; DOI: 10.12659/MSM.947105
Database Analysis
Development and Validation of a Competitive Risk Model in Elderly Patients with Transitional Cell Bladder C...Med Sci Monit In Press; DOI: 10.12659/MSM.946332
Most Viewed Current Articles
17 Jan 2024 : Review article 6,964,204
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 700,526
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 24,009
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 18,806
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912